Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Net Income (2022 - 2025)

Historic Net Income for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$6.0 million.

  • PAVmed's Net Income changed N/A to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $28.4 million for FY2024, which is 13586.41% up from last year.
  • Latest data reveals that PAVmed reported Net Income of -$6.0 million as of Q3 2025.
  • PAVmed's 5-year Net Income high stood at $18.6 million for Q1 2025, and its period low was -$29.9 million during Q3 2022.
  • For the 4-year period, PAVmed's Net Income averaged around -$15.3 million, with its median value being -$18.2 million (2023).
  • Its Net Income has fluctuated over the past 5 years, first tumbled by 1314.62% in 2023, then surged by 20059.96% in 2025.
  • Over the past 4 years, PAVmed's Net Income (Quarter) stood at -$24.6 million in 2022, then rose by 29.16% to -$17.4 million in 2023, then surged by 106.56% to $1.1 million in 2024, then tumbled by 626.36% to -$6.0 million in 2025.
  • Its Net Income was -$6.0 million in Q3 2025, compared to -$12.3 million in Q2 2025 and $18.6 million in Q1 2025.